Quanterix Corporation

Quanterix Corporation

QTRXยทNASDAQ

$3.53

+2.3%
HealthcareMedical - Devices

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

At a Glance

Live Snapshot
Market Cap$166.28M
EPS-2.5100
P/E Ratio-1.41
Earnings Date08/06/2026

No Dividend Yield Data

QTRX has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

QTRX has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

QTRX has not reported any net dividends paid values in the available annual periods.

Quanterix Corporation

Quanterix Corporation Dividend History

QTRX ยท NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

QTRX Dividend Payment History

QTRX ยท NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
qtrx

Quanterix Corporation Payout Ratio Analysis

QTRX ยท NASDAQ
Dividends Paid
0.00
2025
Net Income
-107.15M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.

Sustainability
At Risk

Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.